Risk of CNS relapse after systemic relapse of childhood acute lymphoblastic leukemia.
Fengler
R
R
Department of Pediatrics, Freie Universität, Berlin, FRG.
Hartmann
R
R
Bode
U
U
Janka
G
G
Jürgens
H
H
Riehm
H
H
Henze
G
G
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001932:Brain Neoplasms / Q000453:epidemiology* / Q000517:prevention & control; D002648:Child; D005260:Female; D005860:Germany, West / Q000453:epidemiology; D006801:Humans; D007262:Infusions, Intravenous; D007278:Injections, Spinal; D015993:Life Tables; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D015337:Multicenter Studies as Topic; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000453:epidemiology / Q000473:pathology*; D012074:Remission Induction; D013120:Spinal Cord Neoplasms / Q000453:epidemiology* / Q000517:prevention & control
D008727:Methotrexate